Résumé :
|
ObjectiveIn 2013, the USPSTF issued a Grade B recommendation that long-term current and former smokers receive lung cancer screening. Shared decision-making is important for individuals considering screening, and patient-provider discussions an essential component of the process. We examined prevalence and predictors of lung cancer screening discussions pre- and post-USPSTF guidelines.MethodsData were obtained from two cycles of the Health Information National Trends Survey (2012, 2014). The analyzed sample comprised screening-eligible current and former smokers with no personal history of lung cancer (n = 746 in 2012, n = 795 in 2014). Descriptive and multiple logistic regression analyses were conducted, patient-reported discussion about lung cancer screening with provider was the outcome of interest.ResultsContrary to expectations, patient-provider discussions about lung cancer screening were more prevalent pre-guideline, but overall patient-provider discussions were low in both years (17% in 2012, 10% in 2014). Current smokers were more likely to have had a discussion than former smokers. Significant predictors of patient-provider discussions included family history of cancer and having healthcare coverage.ConclusionsThe prevalence of patient-provider discussions about lung cancer screening is suboptimal.Practice implicationsThere is a critical need for patient and provider education about shared decision-making and its importance in cancer screening decisions.
|